Free Trial

NLS Pharmaceutics (NLSPW) Competitors

NLS Pharmaceutics logo
$0.0056 +0.00 (+9.80%)
(As of 11:33 AM ET)

NLSPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying NLS Pharmaceutics stock or one of its competitors? The main competitors of NLS Pharmaceutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

NLS Pharmaceutics vs.

180 Life Sciences (NASDAQ:ATNFW) and NLS Pharmaceutics (NASDAQ:NLSPW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, community ranking, profitability, media sentiment, valuation and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
NLS PharmaceuticsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
NLS Pharmaceutics N/A N/A N/A

In the previous week, NLS Pharmaceutics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that NLS Pharmaceutics is being referred to more favorably in the news media.

Company Overall Sentiment
180 Life Sciences Neutral
NLS Pharmaceutics Positive

180 Life Sciences and NLS Pharmaceutics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
NLS PharmaceuticsN/AN/A

Summary

NLS Pharmaceutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NLSPW vs. The Competition

MetricNLS PharmaceuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$202.11M$5.13B$9.28B
Dividend YieldN/A3.54%4.81%4.06%
P/E RatioN/A316.48135.2417.51
Price / SalesN/A15,204.511,174.53134.92
Price / CashN/A11.6740.4837.95
Price / BookN/A7.264.884.94
Net IncomeN/A-$18.52M$118.56M$225.30M
7 Day PerformanceN/A181.94%14.97%-1.11%
1 Month PerformanceN/A131.30%15.07%7.29%
1 Year PerformanceN/A112.50%34.31%23.06%

NLS Pharmaceutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NLSPW
NLS Pharmaceutics
N/A$0.01
+9.8%
N/AN/A$0.00N/A0.006Positive News
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+41.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/A$0.04
-25.7%
N/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.16
+6.2%
N/A+4.1%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040Positive News
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+12.9%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.7799 of 5 stars
$12.05
+2.1%
$18.00
+49.4%
+13.9%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
-0.1%
N/A+263.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/AN/A$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:NLSPW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners